foxo4 dri senolytic peptide human trials

foxo4 dri senolytic peptide human trials FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Chondrocytes (PDF) Senolytic Peptide FOXO4-DRI Selectively

Name: foxo4 dri senolytic peptide human trials FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Chondrocytes (PDF) Senolytic Peptide FOXO4-DRI Selectively
Brand: trustt.digital
SKU: 51316619828
Price: 22.44 USD
Availability: InStock
Rating: 4.0117 (10 reviews)

(PDF) Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI FOXO4 p53 Peptide Peptagon Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect

SKU: 51316619828 · From trustt.digital

4.0

USD22.44 USD58.44

Pay in 4 interest-free payments of $5.61 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

baseline)

10 mg Vial Protocol (2 mL = 5 mg/mL) - RECOMMENDED 20 mg Vial Protocol (4 mL = 5 mg/mL) Reconstitution: Add 4.0 mL bacteriostatic water 5 mg/mL concentration